Search for: "In Re: Pfizer Securities Litigation"
Results 1 - 20
of 105
Sort by Relevance
|
Sort by Date
8 Mar 2024, 12:30 pm
Seventh Circuit: Sovereign immunity means never having to say you're sorry. [read post]
8 Jun 2023, 7:43 am
According to Pfizer, [read post]
8 Jun 2023, 7:43 am
Horizon’s strategy shifted over time, however, with the firm seeking to purchase undervalued therapeutics from bankrupt pharmaceutical companies and then re-launch them. [read post]
31 Oct 2022, 5:00 am
This “patent linkage” issue can trigger patent litigation. [read post]
13 Mar 2022, 9:41 am
Worst of all, they also refused to divulge the purchase price–even though we're talking about public money. [read post]
2 Mar 2022, 2:33 pm
That’s why the NATO Alliance was created to secure peace and stability in Europe after World War 2. [read post]
18 Feb 2022, 7:33 am
The FTC’s case against Illumina’s re-acquisition of GRAIL relies on theoretical predictions of consumer harm in a market that is not yet operational. [read post]
10 Jan 2022, 4:01 pm
Hacked Off has re-published lessons from the phone hacking scandal: 10 years on, first published on Campaign.org. [read post]
25 Sep 2021, 2:36 pm
Minn. 2021) (noting how an individual's prior infection with COVID-19 "provide[d] him with some natural immunity and lessen[[ed] his risk of re-infection"). [read post]
9 Aug 2021, 2:02 am
Are companies securing unwarranted monopoly power by raising barriers to litigating the validity of their patents? [read post]
1 Sep 2020, 4:19 pm
Attorneys say they not only drive up the cost of litigation and discourage people from suing for benefits they’re owed, they violate the law Congress passed to protect the millions of people who participate in employee benefit plans, which include retirement, pension, 401(k), health-care, disability and life insurance plans. [read post]
9 Mar 2020, 1:21 pm
Would help litigation, clarity. $3 million to litigate a patent, which is a big expense. [read post]
31 May 2019, 8:39 am
Pfizer, Inc., 2016 WL 4548101, at *5 (Del. [read post]
12 Nov 2017, 11:00 pm
Building on its recent decision in In re Petrobras Securities Litigation,[9] the Second Circuit held that a plaintiff need not always offer direct event study evidence of a cause-and-effect relationship between new information and stock price movements before satisfying its burden to prove market efficiency at the class certification stage. [read post]
27 Aug 2017, 10:01 pm
See In re Lipitor Antitrust Litig., 46 F. [read post]
27 Aug 2017, 10:01 pm
See In re Lipitor Antitrust Litig., 46 F. [read post]
25 May 2017, 5:00 am
Did they throw you right into litigation? [read post]
1 Mar 2017, 3:08 pm
In Re Lipitor Marketing, Sales Practices and Products Liability Litigation, 2016 WL 7338594 (D.S.C. [read post]
25 May 2016, 3:46 pm
” In In re Pfizer Inc. [read post]
14 Apr 2016, 4:59 pm
That theory has been a primary enabler of class action securities litigation under Section 10(b) of the Securities Exchange Act of 1934. [read post]